9.3 Emergent Postoperative Complications: Laryngospasm, Hemorrhage & Hypothermia

Emergent Postoperative Complications: Laryngospasm, Hemorrhage & Hypothermia

Core Principle: Postanesthesia emergencies in ambulatory surgical centers require rapid diagnostic pattern recognition and decisive clinical execution. Freestanding ASCs operate without inpatient intensive care units, hospital code teams, or on-site blood banks. The ambulatory perioperative nurse must possess expert mastery over time-critical interventions: terminating vocal cord spasm before anoxic brain injury or negative pressure pulmonary edema occurs, controlling acute surgical hemorrhage, and preventing the systemic cascade of unintentional hypothermia.

---

Acute Laryngospasm: Pathophysiology, Triggers & Clinical Recognition

Laryngospasm is a primitive protective airway reflex mediated by the superior laryngeal nerve (sensory afferent limb) and the recurrent laryngeal nerve (motor efferent limb). Sensory stimulation of the laryngeal mucosa triggers involuntary, forceful, prolonged contraction of the intrinsic and extrinsic laryngeal musculature (primarily the lateral cricoarytenoid, thyroarytenoid, and cricothyroid muscles), causing complete apposition of the true and false vocal cords and aryepiglottic folds, sealing the glottic aperture.

┌────────────────────────────────────────────────────────────────────────┐
│         THE REFLEX ARC & DYNAMICS OF POSTOPERATIVE LARYNGOSPASM        │
├────────────────────────────────────────────────────────────────────────┤
│ SENSORY STIMULUS (Mucus, blood, suction catheter, light emergence)    │
│    ↳ Afferent Limb: Internal branch of Superior Laryngeal Nerve (CN X) │
│                                                                        │
│ BRAINSTEM INTEGRATION (Nucleus tractus solitarius / Medulla)           │
│                                                                        │
│ MOTOR OUTPUT (Violent adduction of true & false vocal cords)           │
│    ↳ Efferent Limb: Recurrent Laryngeal Nerve (CN X)                   │
│    ↳ Result: Complete Glottic Seal & Total Absence of Ventilation      │
└────────────────────────────────────────────────────────────────────────┘

Perioperative Triggers

Laryngospasm occurs almost exclusively during Stage II of anesthesia (the excitement/emergence phase)—a state where cortical suppression is present while primitive brainstem protective reflexes remain hyperactive. Common precipitating triggers include:

1. Pharyngeal Secretions & Blood: Saliva, mucus, surgical irrigation, or blood trickling onto the glottis.
2. Mechanical Stimulation: Suctioning the posterior pharynx during emergence, extubating in Stage II ("light plane"), or inserting an oral airway into a semi-conscious patient.
3. Patient Vulnerabilities: Pediatric patients (narrower airways, hyper-reactive laryngeal reflexes), recent upper respiratory infection (URI within preceding 2 to 4 weeks), active asthma, and exposure to environmental tobacco smoke.

Clinical Presentation: Partial vs. Complete Laryngospasm

---

Emergency Management of Laryngospasm: The Larson Maneuver & Succinylcholine Protocol

When acute laryngospasm occurs, the nurse must act instantaneously. Every second of delay exacerbates severe hypoxemia, anoxic brain damage, and acute negative pressure pulmonary edema.

Step-by-Step Laryngospasm Treatment Algorithm

1. Alert Team & Terminate Stimulation: Immediately call for the anesthesia provider and second RN. Cease all surgical stimulation, dressing tape manipulation, or patient repositioning.
2. Gentle Pharyngeal Suctioning: Clear blood and secretions using a rigid tonsil-tip (Yankauer) suction under direct vision. Avoid touching the sensitive posterior pharyngeal wall, which compounds reflex adduction.
3. 100% Positive Pressure Mask Ventilation: Apply a tight two-handed mask seal to the patient's face using an anatomical bag-valve-mask or anesthesia circuit. Close the adjustable pressure-limiting (APL) valve partially to deliver continuous positive airway pressure (CPAP) of 15 to 30 cm H₂O with 100% FiO₂. Continuous positive pressure acts as a pneumatic splint, physically pushing the adducted false vocal cords and aryepiglottic folds apart.
4. Execute the Larson Maneuver ("Laryngospasm Notch"):
   • Anatomical Landmark: Locate the laryngospasm notch situated bilaterally behind the ascending ramus and condyle of the mandible, anterior to the mastoid process, and superior to the skull base.
   • Technique: Place the middle or ring fingers of both hands directly into the depression of the laryngospasm notch bilaterally. Apply intense, firm, steady inward (medial) and anterior/cephalad pressure directly toward the base of the skull, while simultaneously thrusting the mandible forward.
   • Physiological Mechanism: Deep periosteal pressure in the notch produces severe, localized painful stimulation that reflexively relaxes laryngeal adductor tone via cranial nerves VII, IX, and X, while the forward jaw thrust lifts the epiglottis away from the glottic aperture.
5. Deepen Anesthesia: If the spasm does not break within 15 to 20 seconds, administer a small intravenous bolus of propofol (0.5 to 1.0 mg/kg IV) to transition the patient from Stage II into Stage III surgical anesthesia.
6. Pharmacological Neuromuscular Blockade (Succinylcholine): If refractory to CPAP, Larson maneuver, and propofol, immediate pharmacological paralysis is required:
   • Low-Dose (Subparalytic) IV Dose: Administer succinylcholine 0.1 to 0.2 mg/kg IV (typically 10 to 20 mg in an adult). This ultra-low dose selectively relaxes the delicate laryngeal vocal cord adductors within 20 to 30 seconds while largely preserving diaphragmatic respiratory excursion, allowing the patient to resume spontaneous ventilation without necessitating full intubation.
   • Full Intubating IV Dose: Administer 1.0 to 1.5 mg/kg IV if bag-mask ventilation remains impossible or endotracheal intubation is mandatory.
   • Intramuscular (IM) Rescue Dose: If intravenous access has infiltrated or been lost, administer succinylcholine 2.0 to 4.0 mg/kg IM (or 1.0 to 2.0 mg/kg IM into the vascular deltoid or intralingual submental muscle). Onset via IM injection is delayed (2 to 4 minutes).
   • Pediatric Pre-treatment with Atropine: When administering succinylcholine to pediatric patients, co-administer atropine (0.02 mg/kg IV/IM, minimum 0.1 mg) to prevent catastrophic succinylcholine-induced vagal bradycardia, nodal rhythms, or sinus arrest.

---

Negative Pressure Pulmonary Edema (NPPE / Type I)

Negative Pressure Pulmonary Edema (NPPE), also known as post-obstructive pulmonary edema, is a life-threatening complication that develops in up to 10% to 11% of patients experiencing acute complete airway obstruction, particularly young, muscular, healthy patients who generate massive inspiratory efforts against a closed glottis.

Pathophysiological Cascade

┌────────────────────────────────────────────────────────────────────────┐
│         PATHOPHYSIOLOGICAL MECHANISM OF TYPE I NEGATIVE PRESSURE EDEMA │
├────────────────────────────────────────────────────────────────────────┤
│ 1. Complete Glottic Obstruction (Laryngospasm, Biting ETT, Strangulat.)│
│                                                                        │
│ 2. Violent Inspiratory Effort against Closed Glottis (Mueller Maneuver)│
│    ↳ Intrathoracic pressure plunges to extreme negative levels         │
│      (from normal -4 mmHg down to -50 to -100 cm H2O)                  │
│                                                                        │
│ 3. Massive Surge in Venous Return to Right Heart                       │
│    ↳ Pulmonary microvascular hydrostatic pressure skyrockets           │
│                                                                        │
│ 4. Capillary Endothelial Stress Failure & Disruption                   │
│    ↳ Alveolar-capillary barrier fractures; massive transudation of     │
│      proteinaceous fluid and RBCs into alveoli                         │
│                                                                        │
│ 5. Clinical Manifestation: Copious Pink, Frothy Alveolar Sputum        │
└────────────────────────────────────────────────────────────────────────┘

Clinical Presentation and Management in the ASC

• Presentation: NPPE typically manifests within 2 to 5 minutes after the relieving of complete laryngospasm or extubation. The patient exhibits acute tachypnea, severe agitation, dyspnea, falling SpO₂ refractory to standard oxygen, diffuse bilateral rales and crackles across all lung fields, and coughing up or filling the airway with characteristic copious, pink, frothy sputum.
• Immediate Interventions:
  1. Position the patient in high Fowler's position (head of bed elevated 60° to 90°) to reduce central venous pooling.
  2. Administer 100% oxygen via continuous positive airway pressure (CPAP) or non-invasive positive pressure ventilation (BiPAP) to maintain alveolar patency and drive fluid back into the pulmonary vascular bed.
  3. If respiratory failure progresses, perform immediate endotracheal re-intubation and apply Positive End-Expiratory Pressure (PEEP of 5 to 10 cm H₂O).
  4. Suction the airway gently; do not deep-suction continuously, as clearing pink froth without positive pressure worsens capillary stress failure.
  5. Judicious loop diuretics (furosemide 20–40 mg IV) may be ordered if the patient is hypervolemic, but are secondary to mechanical PEEP.
  6. Mandatory Transfer to Acute Care Hospital: Freestanding ASCs cannot provide overnight mechanical ventilation or hemodynamic monitoring. The nurse must activate the facility's emergency transfer procedure and dispatch EMS for inpatient critical care admission.

---

Postoperative Surgical Hemorrhage & Expanding Hematomas

Postoperative hemorrhage in the ambulatory setting is an acute surgical emergency. Freestanding ASCs maintain specialized instrumentation but lack on-site blood banks. Prompt clinical detection and protocolized action are vital to patient survival.

Recognizing Hypovolemic Shock in Phase I

• Class I Hemorrhage ($<15%$ blood loss / $<750\text{ mL}$): Minimal physiological disturbance; mild anxiety; normal vitals.
• Class II Hemorrhage ($15%$ to $30%$ blood loss / $750$ to $1,500\text{ mL}$): Compensatory tachycardia ($HR >100\text{ bpm}$), tachypnea ($RR 20-30\text{ breaths/min}$), narrowing pulse pressure (e.g., blood pressure shifting from 120/80 to 105/85 mmHg due to elevated systemic vascular resistance), delayed capillary refill ($>3\text{ seconds}$), and cool, pale extremities.
• Class III Hemorrhage ($30%$ to $40%$ blood loss / $1,500$ to $2,000\text{ mL}$): Decompensated shock. Marked hypotension ($SBP <90\text{ mmHg}$), severe tachycardia ($HR >120\text{ bpm}$), oliguria, marked diaphoresis, pallor, confusion, and agitation.

Expanding Surgical Hematomas: The Emergent Airway Threat

In ambulatory head, neck, and endocrine procedures (e.g., thyroidectomy, carotid endarterectomy, anterior cervical discectomy and fusion [ACDF], tonsillectomy), hemorrhage occurs into a closed fascial compartment. An expanding neck hematoma does not compress the carotid arteries; rather, it produces acute extrinsic mechanical compression of the trachea and laryngeal edema.

• Clinical Signs: Neck fullness, visible swelling under the incision, tracheal deviation, difficulty swallowing, restlessness, and progressive inspiratory stridor.
• Critical Bedside Nursing Action: If a patient with a neck hematoma develops respiratory distress or stridor, immediately cut the sutures, open the surgical wound, and evacuate the hematoma at the bedside. Securing the airway via endotracheal intubation through an extrinsic compressive mass is exceptionally difficult and often impossible; releasing wound tension immediately restores airway patency before the patient suffocates.

Immediate ASC Bleeding Response Protocol

1. Direct Digital Tamponade: Apply firm, continuous direct pressure over the bleeding site with sterile gauze. Apply pressure dressings if appropriate.
2. High-Flow Oxygen: Apply 100% FiO₂ via non-rebreather mask to maximize tissue oxygen delivery.
3. Establish Secondary Large-Bore Vascular Access: Ensure at least two functioning peripheral IV lines (minimum 16-gauge or 18-gauge); never attempt resuscitation through a 22-gauge line.
4. Volume Resuscitation: Infuse warmed balanced isotonic crystalloids (Lactated Ringer's or Plasmalyte) via pressure infusion bags to maintain mean arterial pressure ($MAP \ge 65\text{ mmHg}$).
5. Immediate Notification: Simultaneously summon the operating surgeon and anesthesia provider to the PACU bedside.
6. OR Re-Exploration vs. 911 / EMS Transfer: The surgical team must decide immediately whether to return the patient to the facility's operating room for emergency surgical hemostasis or activate 911 for paramedic transport to the affiliated receiving hospital.

---

Unintentional Perioperative Hypothermia & Active Warming Protocols

Unintentional perioperative hypothermia is defined as a core body temperature $<36.0^\circ\text{C}$ ($96.8^\circ\text{F}$). Anesthetic agents disrupt hypothalamic thermoregulation, eliminate behavioral responses, and induce peripheral vasodilation, causing a rapid core-to-peripheral redistribution of body heat within the first 30 to 60 minutes after induction. Exposure to cold operating room environments, unheated intravenous fluids, and cold skin prep compounds heat loss.

The Physiological Cascade of Hypothermia

┌────────────────────────────────────────────────────────────────────────┐
│         SYSTEMIC COMPLICATIONS OF PERIOPERATIVE HYPOTHERMIA            │
├──────────────────────────┬─────────────────────────────────────────────┤
│ PHYSIOLOGICAL SYSTEM     │ CLINICAL COMPLICATION & IMPACT              │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Coagulation Cascade      │ • Impairs platelet aggregation & activation │
│                          │ • Decreases clotting enzyme activity        │
│                          │ • Each 1°C drop increases blood loss ~16%   │
│                          │ • Relative risk of transfusion rises ~22%   │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Postoperative Shivering  │ • Increases muscular oxygen demand 100-400% │
│                          │ • Triggers carbon dioxide retention         │
│                          │ • Induces lactic acidosis & tachycardia     │
│                          │ • Precipitates myocardial ischemia in CAD   │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Pharmacokinetics         │ • Diminishes hepatic clearance of sedatives │
│                          │ • Prolongs neuromuscular block duration     │
│                          │ • Delays PACU emergence & discharge         │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Immune & Wound Healing   │ • Induces peripheral vasoconstriction       │
│                          │ • Decreases tissue oxygen tension (PO2)     │
│                          │ • Blunts neutrophil bacterial killing       │
│                          │ • 3-fold increase in SSI incidence          │
└──────────────────────────┴─────────────────────────────────────────────┘

Forced-Air Warming Protocols & Nursing Interventions

1. Preoperative Active Prewarming: Applying a forced-air warming blanket set to 38°C to 43°C for 15 to 30 minutes preoperatively vasodilates peripheral tissues and eliminates the core-to-peripheral temperature gradient, preventing the initial redistribution temperature drop after induction.
2. Phase I PACU Active Rewarming:
   • Apply a forced-air warming gown/blanket across the patient's body immediately upon admission if core temperature is $<36.0^\circ\text{C}$.
   • Use inline intravenous fluid warmers for crystalloid infusions exceeding 500 mL.
   • Deliver humidified, warmed supplemental oxygen.
   • Keep head covered with warm blankets or reflective caps (significant heat loss occurs through the scalp).
3. Pharmacological Management of Postoperative Shivering: Severe shivering must be arrested immediately to prevent catastrophic myocardial ischemia. The drug of choice is intravenous meperidine (Demerol 12.5 to 25 mg IV). Meperidine acts on kappa-opioid receptors in the central thermoregulatory center, directly lowering the shivering threshold without causing excessive sedation or respiratory depression. Alternative agents include clonidine (0.5 to 1.0 mcg/kg IV) or dexmedetomidine.
4. Discharge Normothermia Criteria: A patient cannot be discharged from Phase I or transferred to Phase II recovery until normothermia is restored, defined as a verified core temperature of $\ge 36.0^\circ\text{C}$ ($96.8^\circ\text{F}$).